To include your compound in the COVID-19 Resource Center, submit it here.

RoActemra regulatory update

The European Commission approved an extended indication for Roche's RoActemra tocilizumab to include the treatment of

Read the full 164 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE